[
    [
        {
            "time": "",
            "orginal_text": "智飞生物跌4% 上月底中金公司西部证券中泰证券喊买",
            "features": {
                "keywords": [
                    "智飞生物",
                    "下跌",
                    "中金公司",
                    "西部证券",
                    "中泰证券",
                    "买入建议"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "智飞生物跌4% 上月底中金公司西部证券中泰证券喊买",
            "scores": {
                "News_content": "智飞生物跌4% 上月底中金公司西部证券中泰证券喊买",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "独家丨康希诺首次披露：单针新冠疫苗接种6个月后加强免疫抗体提升10倍",
            "features": {
                "keywords": [
                    "康希诺",
                    "新冠疫苗",
                    "单针",
                    "抗体提升",
                    "加强免疫"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "独家丨康希诺首次披露：单针新冠疫苗接种6个月后加强免疫抗体提升10倍",
            "scores": {
                "News_content": "独家丨康希诺首次披露：单针新冠疫苗接种6个月后加强免疫抗体提升10倍",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "智飞生物(300122)事项点评报告：重组新冠疫苗获批紧急使用 自研能力进一步凸显",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组新冠疫苗",
                    "紧急使用",
                    "自研能力"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "智飞生物(300122)事项点评报告：重组新冠疫苗获批紧急使用 自研能力进一步凸显",
            "scores": {
                "News_content": "智飞生物(300122)事项点评报告：重组新冠疫苗获批紧急使用 自研能力进一步凸显",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "万联证券：智飞生物（300122.SZ）重组新冠疫苗获批紧急使用，维持“买入”评级",
            "features": {
                "keywords": [
                    "万联证券",
                    "智飞生物",
                    "重组新冠疫苗",
                    "紧急使用",
                    "买入评级"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "万联证券：智飞生物（300122.SZ）重组新冠疫苗获批紧急使用，维持“买入”评级",
            "scores": {
                "News_content": "万联证券：智飞生物（300122.SZ）重组新冠疫苗获批紧急使用，维持“买入”评级",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业：业绩弹性逐步释放 关注一季报高增长品种",
            "features": {
                "keywords": [
                    "医药生物",
                    "业绩弹性",
                    "一季报",
                    "高增长"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业：业绩弹性逐步释放 关注一季报高增长品种",
            "scores": {
                "News_content": "医药生物行业：业绩弹性逐步释放 关注一季报高增长品种",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "富时罗素季调盘后生效叠加期指交割，波动日如何保平安？",
            "features": {
                "keywords": [
                    "富时罗素",
                    "季调盘",
                    "期指交割",
                    "波动"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "市场整体"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "富时罗素季调盘后生效叠加期指交割，波动日如何保平安？",
            "scores": {
                "News_content": "富时罗素季调盘后生效叠加期指交割，波动日如何保平安？",
                "Correlation": 2,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]